Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 847,983 | 527,979 | 817,116 | 463,331 | 596,829 |
| Marketable Securities | 250,312 | 278,971 | 194,977 | 200,127 | 204,541 |
| Receivables | 24,633 | 27,431 | 24,517 | 14,208 | 8,732 |
| Inventories | 103,732 | 89,212 | 65,174 | N/A | N/A |
| TOTAL | $1,258,075 | $953,444 | $1,128,009 | $703,964 | $828,574 |
| Non-Current Assets | |||||
| PPE Net | 143,280 | 149,129 | 148,927 | 149,316 | 137,675 |
| Investments And Advances | 136,359 | 172,621 | 135,906 | 164,440 | 188,629 |
| Intangibles | 5,792 | 6,237 | 6,349 | 6,621 | 6,759 |
| Other Non-Current Assets | 2,045 | 2,139 | 2,020 | 2,051 | 2,145 |
| TOTAL | $287,475 | $330,126 | $293,202 | $322,428 | $335,208 |
| Total Assets | $1,545,550 | $1,283,570 | $1,421,211 | $1,026,392 | $1,163,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,017 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 79,321 | 70,296 | 128,336 | 75,704 | 78,829 |
| Other current liabilities | 17,110 | 39,925 | 43 | 175 | 306 |
| TOTAL | $107,007 | $118,731 | $136,926 | $84,707 | $87,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 521,527 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | 8,276 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 161,982 | 119,410 | 112,676 | 113,332 | 107,983 |
| TOTAL | $683,508 | $119,410 | $112,676 | $113,332 | $107,983 |
| Total Liabilities | $790,516 | $238,142 | $249,602 | $198,039 | $195,903 |
| Shareholders' Equity | |||||
| Common Shares | 8,584 | 9,046 | 9,007 | 8,720 | 8,714 |
| Retained earnings | -1,727,462 | -1,672,732 | -1,542,150 | -1,478,947 | -1,317,805 |
| Other shareholders' equity | 251,179 | 241,449 | 222,267 | 209,876 | 190,416 |
| TOTAL | $755,034 | $1,045,429 | $1,171,608 | $828,353 | $967,879 |
| Total Liabilities And Equity | $1,545,550 | $1,283,571 | $1,421,210 | $1,026,392 | $1,163,781 |